Bristol-Myers Squibb Canada Profit Triples on Sale of Device Unit

October 23, 2008 |

1 min read

NEW YORK (Reuters) - Bristol-Myers Squibb Co on Thursday said third-quarter earnings tripled from the sale of its ConvaTec wound-healing unit and higher drug sales, but the company took another big charge for soured investments.

Earnings

MORE ON THIS TOPIC

Target concept vector illustration. Business goal, marketing strategy, digital aim, bullseye accuracy, cyber challenge, innovation target, focus objective, dart board, internet market.

Phase 3

Taiho and Cullinan’s zipalertinib clears Phase 3, teeing up first-line competition

August 13, 2026

·

3 min read

·

Gabrielle Masson

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

MindMaze trims Relief staff, Aardvark cuts workforce amid Prader-Willi troubles

August 13, 2026

·

83 min read

·

BioSpace Editorial Staff

Halftone hands shake coins out of paper money. Modern collage. Concept of inflation, bankruptcy, poverty. Financial difficulties

Rare diseases

Zealand sells milestone, royalty rights to rare blood cancer asset for up to $100M

August 13, 2026

·

2 min read

·

Tristan Manalac

Business bankruptcy assistance concept. businessman on a paper boat and rescues a drowning man vector

Bankruptcy

Bankrupt Sangamo offloads assets to Lilly, PTC in $161M sale

August 13, 2026

·

2 min read

·

Tristan Manalac